Joseph Amprey
Founder at Zero Point Five Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Helen Pentikis | M | - |
Zero Point Five Therapeutics, Inc.
 Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | - |
| Karen Dawes | F | 72 |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | 11 years |
| Jodi S. Jahic | F | - |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | 3 years |
| Benjamin Auspitz | M | 51 |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Jacks | M | - |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | - |
| Klaus Veitinger | M | 62 |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | 1 years |
| Wayne T. Hockmeyer | M | 79 |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 5 years |
| David Mott | M | 58 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 6 years |
| Anthony Zook | M | 63 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | - |
| Steve Pomerantz | M | - |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | - |
| Melvin Booth | M | 79 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | - |
| Franklin H. Top | M | 88 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 22 years |
| Ed Mathers Mathers | M | 64 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 8 years |
| Peter Greenleaf | M | 54 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 3 years |
| Taunia S. Markvicka | M | 56 |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | 4 years |
| Maggie Flanagan LeFlore | M | - |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 3 years |
| Eva M. Jack | F | 56 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 6 years |
| Atul Saran | M | 50 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | - |
| Nikki Adetoro | F | - |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | - |
| Tyrell J. Rivers | M | 51 |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joseph Amprey
- Personal Network
